Letter: risk of hepatocellular carcinoma in immune-tolerant phase of chronic hepatitis B.
作者信息
Gattani Mayur, Ingle Meghraj, Chauhan Shamshersingh, Lad Saiprasad
机构信息
Department of Gastroenterology, Lokmanya Tilak Municipal Medical College & General Hospital, Mumbai, India.
出版信息
Aliment Pharmacol Ther. 2020 Sep;52(5):911-912. doi: 10.1111/apt.15966.
PMID:32852812
Abstract
摘要
相似文献
1
Letter: risk of hepatocellular carcinoma in immune-tolerant phase of chronic hepatitis B.信件：慢性乙型肝炎免疫耐受期肝细胞癌的风险
Aliment Pharmacol Ther. 2020 Sep;52(5):911-912. doi: 10.1111/apt.15966.
2
Letter: risk of hepatocellular carcinoma in immune-tolerant phase of chronic hepatitis B-authors' reply.信函：慢性乙型肝炎免疫耐受期肝细胞癌的风险——作者回复
Aliment Pharmacol Ther. 2020 Sep;52(5):913-914. doi: 10.1111/apt.15992.
3
Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase.在免疫耐受期的慢性乙型肝炎患者中，肝细胞癌发展的风险极低。
Aliment Pharmacol Ther. 2020 Jul;52(1):196-204. doi: 10.1111/apt.15741. Epub 2020 May 26.
4
Letter: serum hepatitis B virus DNA and risk of hepatocellular carcinoma in patients with chronic hepatitis B.信函：慢性乙型肝炎患者血清乙肝病毒DNA与肝细胞癌风险
Aliment Pharmacol Ther. 2021 Mar;53(6):761-762. doi: 10.1111/apt.16264.
5
Letter: serum hepatitis B virus DNA and risk of hepatocellular carcinoma in patients with chronic hepatitis B-authors' reply.信函：慢性乙型肝炎患者血清乙肝病毒DNA与肝细胞癌风险——作者回复
Aliment Pharmacol Ther. 2021 Mar;53(6):763. doi: 10.1111/apt.16278.
6
Natural history of chronic hepatitis B: extending the REVEAL study.
Liver Int. 2010 Sep;30(8):1085-6. doi: 10.1111/j.1478-3231.2010.02277.x. Epub 2010 May 21.
7
High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B.免疫耐受期慢性乙型肝炎患者发生肝细胞癌和死亡的风险较高。
Gut. 2018 May;67(5):945-952. doi: 10.1136/gutjnl-2017-314904. Epub 2017 Oct 21.
8
[Epidemiology of HBV related hepatocellular carcinoma in Japan].[日本乙型肝炎病毒相关肝细胞癌的流行病学]
Nihon Rinsho. 1995 Oct;53 Suppl(Pt 2):673-9.
9
HBV genotype and clinical outcome of chronic hepatitis B: facts and puzzles.乙肝病毒基因型与慢性乙型肝炎的临床结局：事实与谜题
Gastroenterology. 2008 Apr;134(4):1272-3; author reply 1273. doi: 10.1053/j.gastro.2007.12.046.
10
Hepatocellular carcinoma risk stratification in HBV cirrhosis: Time to turn the page?乙肝肝硬化患者肝细胞癌的风险分层：是时候翻开新篇章了吗？
J Hepatol. 2020 Sep;73(3):728-729. doi: 10.1016/j.jhep.2020.04.018. Epub 2020 May 15.
Zotero 插件